Ebola; Viruses; Vaccines; Cold and Flu; Virology; Bird Flu Research; Pests and Parasites; Invasive Species

Johnson & Johnson's two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published in The Lancet Infectious Diseases. The EBOVAC-Salone…